bluebird bio, Inc. (BLUE) Social Stream



bluebird bio, Inc. (BLUE): $5.05

0.77 (+17.99%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add BLUE to Watchlist
Sign Up

Industry: Biotech


Ranked

of 400

in industry

bluebird bio Inc (BLUE) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering BLUE.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 14 $45 $11 $23.09 $4.96 365.52%
2021-11-15 14 $45 $11 $22.8 $4.96 359.68%
2021-11-19 14 $45 $11 $20.2 $4.96 307.26%
2021-12-20 13 $45 $11 $20.2 $4.96 307.26%
2022-01-06 13 $45 $10 $20.1 $4.96 305.24%
2022-01-18 13 $45 $10 $19.9 $4.96 301.21%
2022-02-01 13 $45 $6 $19.5 $4.96 293.15%
2022-03-07 12 $45 $6 $19.5 $4.96 293.15%
2022-03-09 13 $45 $4 $18.333 $4.96 269.62%

The Trend in the Analyst Price Target


BLUE's average price target has moved down $87.43 over the prior 18 months.

Over the past 121 days, BLUE's average upside potential has been 176.72%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-08 14 45 11 23.090 10.70 115.79%
2021-11-08 14 45 11 23.600 10.70 120.56%
2022-01-18 13 45 10 19.900 7.91 151.58%
2022-03-09 13 45 4 17.900 4.84 269.83%
2022-03-09 13 45 4 18.333 4.84 278.78%

BLUE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.95 2 0 9 2 2 13

The Trend in the Broker Recommendations


Over the past 59 days, BLUE's average broker recommendation rating worsened by 0.15.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • BLUE has a lower variance in analysts' estimates than -1182.85% of all US stocks.
  • In the context of stocks in the large market cap category, bluebird bio Inc's upside potential (average analyst target price relative to current price) is greater than 1288.96% of them.
  • To contextualize these metrics, consider that out of stocks in the large market cap category, bluebird bio Inc's average analyst price target is higher than 117.48% of them.
  • In terms of how bluebird bio Inc fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is greater than 1152.98% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to bluebird bio Inc are BIIB, ARGX, and AMGN.

What is the outlook for BLUE? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4938 seconds.